Healthcare provider profile · identity verified

Robert Charkowick, DO

Family Practice · PORT ST LUCIE, FL · NPI 1649362260

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	782	244
Atorvastatin Calcium	Atorvastatin Calcium	635	212
Levothyroxine Sodium	Levothyroxine Sodium	465	135
Rosuvastatin Calcium	Rosuvastatin Calcium	433	150
Losartan Potassium	Losartan Potassium	354	111
Metformin Hcl	Metformin Hcl	324	118
Lisinopril	Lisinopril	321	109
Alprazolam	Alprazolam	306	82
Pantoprazole Sodium	Pantoprazole Sodium	290	102
Simvastatin	Simvastatin	269	79
Metoprolol Succinate	Metoprolol Succinate	239	85
Tamsulosin Hcl	Tamsulosin Hcl	236	79
Hydrochlorothiazide	Hydrochlorothiazide	235	82
Omeprazole	Omeprazole	223	74
Gabapentin	Gabapentin	220	90
Sertraline Hcl	Sertraline Hcl	200	83
Lorazepam	Lorazepam	192	46
Pravastatin Sodium	Pravastatin Sodium	192	54
Glipizide	Glipizide	181	61
Metoprolol Tartrate	Metoprolol Tartrate	173	56
Albuterol Sulfate Hfa	Albuterol Sulfate	155	48
Temazepam	Temazepam	143	33
Clopidogrel	Clopidogrel Bisulfate	138	47
Allopurinol	Allopurinol	130	48
Furosemide	Furosemide	130	50
Meloxicam	Meloxicam	127	47
Metformin Hcl Er	Metformin Hcl	117	38
Potassium Chloride	Potassium Chloride	114	42
Fluoxetine Hcl	Fluoxetine Hcl	113	34
Carvedilol	Carvedilol	104	29
Montelukast Sodium	Montelukast Sodium	99	34
Atenolol	Atenolol	94	27
Synthroid	Levothyroxine Sodium	94	21
Glimepiride	Glimepiride	93	28
Duloxetine Hcl	Duloxetine Hcl	92	29
Escitalopram Oxalate	Escitalopram Oxalate	89	28
Finasteride	Finasteride	89	30
Tramadol Hcl	Tramadol Hcl	89	28
Trazodone Hcl	Trazodone Hcl	81	24
Zolpidem Tartrate	Zolpidem Tartrate	80	26
Januvia	Sitagliptin Phosphate	75	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	25
Ozempic	Semaglutide	70	14
Clonazepam	Clonazepam	69	15
Fluticasone Propionate	Fluticasone Propionate	67	27
Citalopram Hbr	Citalopram Hydrobromide	65	19
Ezetimibe	Ezetimibe	65	26
Clonidine Hcl	Clonidine Hcl	62	22
Eliquis	Apixaban	62	19
Hydralazine Hcl	Hydralazine Hcl	62	18
Diazepam	Diazepam	59	12
Azithromycin	Azithromycin	58	57
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	15
Cefuroxime	Cefuroxime Axetil	55	48
Xarelto	Rivaroxaban	52	17
Lovastatin	Lovastatin	51	14
Valsartan	Valsartan	51	14
Oxybutynin Chloride Er	Oxybutynin Chloride	49	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	48	32
Donepezil Hcl	Donepezil Hcl	47	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	15
Meclizine Hcl	Meclizine Hcl	46	23
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	11
Famotidine	Famotidine	44	15
Esomeprazole Magnesium	Esomeprazole Magnesium	42	16
Glipizide Er	Glipizide	40	14
Prednisone	Prednisone	40	33
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	34
Valacyclovir	Valacyclovir Hcl	39	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	11
Amoxicillin	Amoxicillin	31	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	18
Bupropion Xl	Bupropion Hcl	30	11
Methylprednisolone	Methylprednisolone	30	28
Benazepril Hcl	Benazepril Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	12
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Ibuprofen	Ibuprofen	28	16
Jardiance	Empagliflozin	28	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	12
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	11
Baclofen	Baclofen	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Cholestyramine	Cholestyramine (With Sugar)	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	17
Dexamethasone	Dexamethasone	21	20
Alendronate Sodium	Alendronate Sodium	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	17	suppressed
Naproxen	Naproxen	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Digoxin	Digoxin	14	suppressed
Estradiol	Estradiol	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Cephalexin	Cephalexin	13	13
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Risperidone	Risperidone	13	suppressed
Topiramate	Topiramate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Colchicine	Colchicine	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error